The deal for Amplitude’s intravascular lithotripsy platform, which closed last week, included $435 million upfront and up to ...

Stryker (NYSE:SYK) disclosed in an SEC Form 10-Q today that its deal to acquire Amplitude Vascular Systems (AVS) is worth up ...

With an intravascular lithotripsy platform, Stryker will enter a booming market that has attracted investment from Johnson & Johnson, Boston Scientific and Abbott.

Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular ...

Stryker (NYSE:SYK) announced today that it completed its acquisition of Amplitude Vascular Systems (AVS) for an undisclosed ...

FastWave Medical, a developer in advanced intravascular lithotripsy (IVL) technology, announced the issuance of its sixth utility patent by the United States Patent and Trademark Office (USPTO). This ...

As 2026 begins, intravascular lithotripsy — or IVL — stands out as one of the most closely watched technologies in cardiovascular intervention. Designed to break up hardened calcium inside arteries, ...

SAN FRANCISCO — Two different balloon devices developed for the treatment of calcified coronary lesions were found noninferior to intravascular lithotripsy (IVL) at a lower cost in separate major ...